BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

546 related articles for article (PubMed ID: 30687306)

  • 1. APOBEC3G Regulation of the Evolutionary Race Between Adaptive Immunity and Viral Immune Escape Is Deeply Imprinted in the HIV Genome.
    Borzooee F; Joris KD; Grant MD; Larijani M
    Front Immunol; 2018; 9():3032. PubMed ID: 30687306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evasion of adaptive immunity by HIV through the action of host APOBEC3G/F enzymes.
    Grant M; Larijani M
    AIDS Res Ther; 2017 Sep; 14(1):44. PubMed ID: 28893290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positioning of APOBEC3G/F mutational hotspots in the human immunodeficiency virus genome favors reduced recognition by CD8+ T cells.
    Monajemi M; Woodworth CF; Zipperlen K; Gallant M; Grant MD; Larijani M
    PLoS One; 2014; 9(4):e93428. PubMed ID: 24722422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Switching and emergence of CTL epitopes in HIV-1 infection.
    Han C; Kawana-Tachikawa A; Shimizu A; Zhu D; Nakamura H; Adachi E; Kikuchi T; Koga M; Koibuchi T; Gao GF; Sato Y; Yamagata A; Martin E; Fukai S; Brumme ZL; Iwamoto A
    Retrovirology; 2014 May; 11():38. PubMed ID: 24886641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Marked epitope- and allele-specific differences in rates of mutation in human immunodeficiency type 1 (HIV-1) Gag, Pol, and Nef cytotoxic T-lymphocyte epitopes in acute/early HIV-1 infection.
    Brumme ZL; Brumme CJ; Carlson J; Streeck H; John M; Eichbaum Q; Block BL; Baker B; Kadie C; Markowitz M; Jessen H; Kelleher AD; Rosenberg E; Kaldor J; Yuki Y; Carrington M; Allen TM; Mallal S; Altfeld M; Heckerman D; Walker BD
    J Virol; 2008 Sep; 82(18):9216-27. PubMed ID: 18614631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence of differential HLA class I-mediated viral evolution in functional and accessory/regulatory genes of HIV-1.
    Brumme ZL; Brumme CJ; Heckerman D; Korber BT; Daniels M; Carlson J; Kadie C; Bhattacharya T; Chui C; Szinger J; Mo T; Hogg RS; Montaner JS; Frahm N; Brander C; Walker BD; Harrigan PR
    PLoS Pathog; 2007 Jul; 3(7):e94. PubMed ID: 17616974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Mutations on Replicative Fitness and Major Histocompatibility Complex Class I Binding Affinity Are Among the Determinants Underlying Cytotoxic-T-Lymphocyte Escape of HIV-1 Gag Epitopes.
    Du Y; Zhang TH; Dai L; Zheng X; Gorin AM; Oishi J; Wu TT; Yoshizawa JM; Li X; Yang OO; Martinez-Maza O; Detels R; Sun R
    mBio; 2017 Nov; 8(6):. PubMed ID: 29184023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Next-generation sequencing analyses of the emergence and maintenance of mutations in CTL epitopes in HIV controllers with differential viremia control.
    Caetano DG; Côrtes FH; Bello G; Teixeira SLM; Hoagland B; Grinsztejn B; Veloso VG; Guimarães ML; Morgado MG
    Retrovirology; 2018 Sep; 15(1):62. PubMed ID: 30201008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Consequences of HLA-B*13-Associated Escape Mutations on HIV-1 Replication and Nef Function.
    Shahid A; Olvera A; Anmole G; Kuang XT; Cotton LA; Plana M; Brander C; Brockman MA; Brumme ZL
    J Virol; 2015 Nov; 89(22):11557-71. PubMed ID: 26355081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired processing and presentation of cytotoxic-T-lymphocyte (CTL) epitopes are major escape mechanisms from CTL immune pressure in human immunodeficiency virus type 1 infection.
    Yokomaku Y; Miura H; Tomiyama H; Kawana-Tachikawa A; Takiguchi M; Kojima A; Nagai Y; Iwamoto A; Matsuda Z; Ariyoshi K
    J Virol; 2004 Feb; 78(3):1324-32. PubMed ID: 14722287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fitness-Balanced Escape Determines Resolution of Dynamic Founder Virus Escape Processes in HIV-1 Infection.
    Sunshine JE; Larsen BB; Maust B; Casey E; Deng W; Chen L; Westfall DH; Kim M; Zhao H; Ghorai S; Lanxon-Cookson E; Rolland M; Collier AC; Maenza J; Mullins JI; Frahm N
    J Virol; 2015 Oct; 89(20):10303-18. PubMed ID: 26223634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dendritic cells focus CTL responses toward highly conserved and topologically important HIV-1 epitopes.
    Garcia-Bates TM; Palma ML; Anderko RR; Hsu DC; Ananworanich J; Korber BT; Gaiha GD; Phanuphak N; Thomas R; Tovanabutra S; Walker BD; Mellors JW; Piazza PA; Kroon E; Riddler SA; Michael NL; Rinaldo CR; Mailliard RB;
    EBioMedicine; 2021 Jan; 63():103175. PubMed ID: 33450518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variable fitness impact of HIV-1 escape mutations to cytotoxic T lymphocyte (CTL) response.
    Troyer RM; McNevin J; Liu Y; Zhang SC; Krizan RW; Abraha A; Tebit DM; Zhao H; Avila S; Lobritz MA; McElrath MJ; Le Gall S; Mullins JI; Arts EJ
    PLoS Pathog; 2009 Apr; 5(4):e1000365. PubMed ID: 19343217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of immune escape mutations on HIV-1 fitness in the context of the cognate transmitted/founder genome.
    Song H; Pavlicek JW; Cai F; Bhattacharya T; Li H; Iyer SS; Bar KJ; Decker JM; Goonetilleke N; Liu MK; Berg A; Hora B; Drinker MS; Eudailey J; Pickeral J; Moody MA; Ferrari G; McMichael A; Perelson AS; Shaw GM; Hahn BH; Haynes BF; Gao F
    Retrovirology; 2012 Oct; 9():89. PubMed ID: 23110705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient processing of the immunodominant, HLA-A*0201-restricted human immunodeficiency virus type 1 cytotoxic T-lymphocyte epitope despite multiple variations in the epitope flanking sequences.
    Brander C; Yang OO; Jones NG; Lee Y; Goulder P; Johnson RP; Trocha A; Colbert D; Hay C; Buchbinder S; Bergmann CC; Zweerink HJ; Wolinsky S; Blattner WA; Kalams SA; Walker BD
    J Virol; 1999 Dec; 73(12):10191-8. PubMed ID: 10559335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genotypic and Mechanistic Characterization of Subtype-Specific HIV Adaptation to Host Cellular Immunity.
    Kinloch NN; Lee GQ; Carlson JM; Jin SW; Brumme CJ; Byakwaga H; Muzoora C; Bwana MB; Cobarrubias KD; Hunt PW; Martin JN; Carrington M; Bangsberg DR; Harrigan PR; Brockman MA; Brumme ZL
    J Virol; 2019 Jan; 93(1):. PubMed ID: 30305354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Viral evolution in HLA-B27-restricted CTL epitopes in human immunodeficiency virus type 1-infected individuals.
    Setiawan LC; Gijsbers EF; van Nuenen AC; Kootstra NA
    J Gen Virol; 2015 Aug; 96(8):2372-2380. PubMed ID: 25872744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The antiviral factor APOBEC3G improves CTL recognition of cultured HIV-infected T cells.
    Casartelli N; Guivel-Benhassine F; Bouziat R; Brandler S; Schwartz O; Moris A
    J Exp Med; 2010 Jan; 207(1):39-49. PubMed ID: 20038599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clustering patterns of cytotoxic T-lymphocyte epitopes in human immunodeficiency virus type 1 (HIV-1) proteins reveal imprints of immune evasion on HIV-1 global variation.
    Yusim K; Kesmir C; Gaschen B; Addo MM; Altfeld M; Brunak S; Chigaev A; Detours V; Korber BT
    J Virol; 2002 Sep; 76(17):8757-68. PubMed ID: 12163596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequent associations between CTL and T-Helper epitopes in HIV-1 genomes and implications for multi-epitope vaccine designs.
    Paul S; Piontkivska H
    BMC Microbiol; 2010 Aug; 10():212. PubMed ID: 20696039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.